Lifestyle Changes for Breast Cancer
(IMPACT-Women Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to explore whether lifestyle changes can assist breast cancer patients during chemotherapy. It will test if time-restricted eating (eating within a specific time window), improved nutrition, and reduced sitting can decrease fat build-up and enhance heart health. Participants will join one of two groups: one follows a structured diet and activity plan, while the other receives general nutrition advice and standard care. Women diagnosed with early to mid-stage breast cancer and starting chemotherapy might be suitable candidates if they are willing to adjust their eating and activity habits. As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance cancer care through lifestyle changes.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you have diabetes and require insulin, you may not be eligible to participate.
What prior data suggests that these lifestyle changes are safe for breast cancer patients?
Research has shown that time-restricted eating (TRE), combined with healthy eating and reduced sedentary behavior, is generally well-tolerated by people with cancer. Studies have found that integrating TRE with these lifestyle changes is both feasible and safe. Specifically, one study discovered that an eight-week period of TRE was manageable for participants and helped lower the risk of heart disease in older breast cancer survivors. These findings suggest that such lifestyle changes can be safely incorporated into the lives of breast cancer patients, potentially leading to better health outcomes.12345
Why are researchers excited about this trial?
Researchers are excited about these lifestyle changes for breast cancer because they offer a fresh approach by focusing on time-restricted eating, nutrition education, and reducing sedentary behavior. Unlike traditional treatments that mainly rely on drugs and chemotherapy, these strategies aim to improve overall health and well-being, potentially enhancing the effectiveness of standard treatments. By incorporating a holistic approach with tools like a Fitbit monitor for tracking progress, these interventions could empower patients to actively participate in their health journey, possibly leading to better outcomes and quality of life during treatment.
What evidence suggests that these lifestyle changes could be effective for breast cancer patients?
Research shows that time-restricted eating (TRE) can benefit people with cancer, including those undergoing chemotherapy for breast cancer. In this trial, participants in the "Time-Restricted Eating and Sedentary Time Reduction" arm will follow TRE, receive nutritional education, and work on reducing sedentary time. Studies have found that TRE, combined with healthy eating and increased activity, may improve treatment outcomes and quality of life. Early findings suggest that TRE is not only feasible and acceptable for cancer patients but may also offer cancer-related benefits. This method could aid in weight management and overall health, potentially lowering the risk of heart problems for breast cancer survivors. These lifestyle changes aim to control unwanted fat in specific areas, which is linked to heart health and fitness.12356
Who Is on the Research Team?
Richard Thompson, PhD
Principal Investigator
University of Alberta
Are You a Good Fit for This Trial?
This trial is for women over 18 with stage I, II, or III breast cancer who are about to start chemotherapy. They must be able to perform daily activities (ECOG <3), have their oncologist's approval, speak English, and commit to the study intervention.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Chemotherapy Treatment
Participants receive standard chemotherapy treatment along with a behavioral intervention involving time-restricted eating, diet quality improvements, and reduced sedentary time
Follow-up
Participants are monitored for changes in ectopic fat, cardiometabolic profile, and chemotherapy outcomes
Long-term Follow-up
Tracking long-term health effects of participation through participants' electronic medical records
What Are the Treatments Tested in This Trial?
Interventions
- Time restricted eating, nutrition education, and sedentary time reduction strategies
Trial Overview
The study tests if a behavioral intervention with time-restricted eating, better diet quality, and less sitting time can reduce fat accumulation and improve heart health compared to standard care in breast cancer patients during chemotherapy.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Group 1 (Experimental intervention): Participants assigned to this group will receive standard chemotherapy treatment plus a dietary program, and sedentary time reduction strategies, program and a Fitbit monitor. If you are randomized into this group, you will be asked to follow TRE, will receive nutritional education and individualized recommendations on improving diet quality and healthy eating practices, and given to strategies to work towards reducing sedentary time. These components will be gradually introduced over the 24-week program.
Group 2 (Non-experimental intervention): Participants randomized to this group will receive standard chemotherapy treatment plus a single, group-based "nutrition during cancer" class, as well as a copy of Canada's Food Guide, physical activity guidelines, and a Fitbit monitor. You will be asked to only make dietary changes if they are recommended within the class or by your doctor, and to maintain your usual timing and number of meals consumed per day. Throughout the 24-week period, you will receive seven brief phone calls from a study staff member to ask about your symptoms and provide support. After the end of the study, participants in this group will be offered a one-one-one counselling session with a registered dietitian.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alberta
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator
Published Research Related to This Trial
Citations
a randomised controlled trial of the effect of time-restricted ...
The purpose of this study is to evaluate the effect of a multimodal intervention consisting of TRE, healthy eating, and reduced sedentary time during ...
Time Restricted Eating During Chemotherapy for Breast ...
The proposed research will demonstrate that time restricted eating, a form of intermittent fasting, will improve treatment related outcomes, patient related ...
Clinical Impact of Time-restricted Eating on Cancer
Preliminary findings suggest that TRE is feasible and acceptable by people with cancer, may have oncological benefits, and improves quality of life.
Time-Restricted Eating: A Novel and Simple Dietary ...
In composite, these data suggest that TRE may be an easy and novel lifestyle interventions for the primary and secondary prevention of breast cancer, as well as ...
The effects of lifestyle and behavioural interventions on ...
This study aimed to assess and compare the effects of lifestyle/behavioural interventions on cancer recurrence, survival and QoL in breast cancer survivors.
Abstract 12484: Weekday 16:8 Time-Restricted Eating in ...
Eight weeks of weekday 16:8 TRE is highly feasible, safe, and reduces CVD risk among older breast cancer survivors with overweight/obesity at moderate CVD risk.
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.